139 related articles for article (PubMed ID: 19282697)
1. Recurrent Escherichia coli bloodstream infections: epidemiology and risk factors.
Sanz-García M; Fernández-Cruz A; Rodríguez-Créixems M; Cercenado E; Marin M; Muñoz P; Bouza E
Medicine (Baltimore); 2009 Mar; 88(2):77-82. PubMed ID: 19282697
[TBL] [Abstract][Full Text] [Related]
2. Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.
Pascual V; Alonso N; Simó M; Ortiz G; Garcia MC; Xercavins M; Rivera A; Morera MA; Miró E; Espejo E; Navarro F; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1997-2003. PubMed ID: 27549108
[TBL] [Abstract][Full Text] [Related]
3. A ten-year review of ESBL and non-ESBL Escherichia coli bloodstream infections among children at a tertiary referral hospital in South Africa.
Malande OO; Nuttall J; Pillay V; Bamford C; Eley B
PLoS One; 2019; 14(9):e0222675. PubMed ID: 31550295
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and impact of bloodstream infections among kidney transplant recipients: A retrospective single-center experience.
Shendi AM; Wallis G; Painter H; Harber M; Collier S
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29151282
[TBL] [Abstract][Full Text] [Related]
6. Seasonal variation in Escherichia coli bloodstream infections in northern Israel.
Chazan B; Colodner R; Edelstein H; Raz R
Clin Microbiol Infect; 2011 Jun; 17(6):851-4. PubMed ID: 20673262
[TBL] [Abstract][Full Text] [Related]
7. Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy.
Widmer AF; Kern WV; Roth JA; Dettenkofer M; Goetting T; Bertz H; Theilacker C;
Infection; 2019 Oct; 47(5):837-845. PubMed ID: 31187401
[TBL] [Abstract][Full Text] [Related]
8. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
9. Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-centre study.
Giannella M; Pascale R; Toschi A; Ferraro G; Graziano E; Furii F; Bartoletti M; Tedeschi S; Ambretti S; Lewis RE; Viale P
Clin Microbiol Infect; 2018 Oct; 24(10):1077-1083. PubMed ID: 29371138
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and microbiological features of recurrent Escherichia coli bloodstream infections.
Kim YC; Choi H; Kim YA; Park YS; Seo YH; Lee H; Lee K
PLoS One; 2023; 18(1):e0280196. PubMed ID: 36626405
[TBL] [Abstract][Full Text] [Related]
11. Planning to halve Gram-negative bloodstream infection: getting to grips with healthcare-associated Escherichia coli bloodstream infection sources.
Otter JA; Galletly TJ; Davies F; Hitchcock J; Gilchrist MJ; Dyakova E; Mookerjee S; Holmes AH; Brannigan ET
J Hosp Infect; 2019 Feb; 101(2):129-133. PubMed ID: 30059746
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
[TBL] [Abstract][Full Text] [Related]
13. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
[TBL] [Abstract][Full Text] [Related]
14. [Patients of
Zhao SJ; Fu YQ; Zhu MX; Zhou H; Xu M; Yan RL; Shui YX; Zhou JY
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(32):2496-2500. PubMed ID: 28835055
[No Abstract] [Full Text] [Related]
15. Risk factors and diagnostic markers for Escherichia coli bloodstream infection in older patients.
Chen Q; Ma G; Cao H; Yang X; Jiang Y
Arch Gerontol Geriatr; 2021; 93():104315. PubMed ID: 33310397
[TBL] [Abstract][Full Text] [Related]
16. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
Cordero L; Rau R; Taylor D; Ayers LW
Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
[TBL] [Abstract][Full Text] [Related]
17. Recurrent gram-negative bloodstream infection: a 10-year population-based cohort study.
Al-Hasan MN; Eckel-Passow JE; Baddour LM
J Infect; 2010 Jul; 61(1):28-33. PubMed ID: 20378069
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli.
Wu UI; Yang CS; Chen WC; Chen YC; Chang SC
J Microbiol Immunol Infect; 2010 Aug; 43(4):310-6. PubMed ID: 20688291
[TBL] [Abstract][Full Text] [Related]
19. Increased incidence of Escherichia coli bacteremia post-Christchurch earthquake 2011: possible associations.
Schousboe M; Lynds J; Ambrose C
Prehosp Disaster Med; 2013 Jun; 28(3):202-9. PubMed ID: 23425528
[TBL] [Abstract][Full Text] [Related]
20. Bacteremias caused by Escherichia coli in cancer patients - analysis of 65 episodes.
Krcmery V; Spanik S; Mrazova M; Trupl J; Grausova S; Grey E; Kukuckova E; Sulcova M; Krupova I; Koren P
Int J Infect Dis; 2002 Mar; 6(1):69-73. PubMed ID: 12044306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
